Searched for
ONCOLOGY SPACE
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- For investors with patience, experience, and anxiety appetite: 5 stocks from different sectors with upside potential of up to 21%For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...
- RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-SeptemberRPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- 'Hospital infra isn't sole determinant of better care, outcomes also matter,' says Max Healthcare ChairmanMax Healthcare has significantly increased its bed capacity to 6,500 with a new Saket facility. This expansion targets both domestic patien...
- MOC Cancer Care raises $18 million from Elevation CapitalThe funds will be used for expanding operations, opening new centres, and diversifying the range of services offered, said the Mumbai-based...
- Fundamental Radar: Why is Beta Drugs a good play in the oncology space? Sandeep Raina explainsBeta Drugs is well placed to capitalise on the growth opportunities in the oncology drugs segment, aided by its comprehensive product portf...
- Lupin gets USD 25 million from AbbVie for meeting key product development milestoneThe company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...
- Bugworks Research bags $18 million in funding round led by Lightrock India, othersBugworks Research said it will continue to invest in its proprietary drug discovery platforms GYROX (for AMR) and DARE (for Immuno-oncology...
- Smallcap Hunters: Why Medicamen looks like a big story in the makingThe company has built world-class facilities in terms of processes etc. No short cuts here.
- Ratan Tata invests in cancer therapeutic startup Invictus OncologyThe startup utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumor and modulate the tumor immun...
- Glenmark Pharmaceuticals discovers new molecule; enters oncology segmentGlenmark announced the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a state...
- Strides Arcolab gets USFDA nod for cancer injectionDrug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...
- Glenmark plans cancer drug unit in ArgentinaMid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina.
- Strides, Aspen ink four JVs to strengthen niche armsIt is raining deals at Bangalore-based mid-sized pharma player Strides Arcolab.
Load More
